Sale!

STAT3 Gene Hyper-IgE recurrent infection syndrome Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The STAT3 Gene Hyper-IgE Recurrent Infection Syndrome Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the STAT3 gene, which are linked to Hyper-IgE Syndrome (HIES). This condition, also known as Job’s Syndrome, is a rare immune disorder characterized by high levels of immunoglobulin E (IgE), eczema, and recurrent skin and lung infections. The test plays a crucial role in the accurate diagnosis and management of HIES, enabling targeted treatment strategies and improved patient care.

Performed using a sample of the patient’s blood or saliva, the test involves advanced genetic sequencing techniques to scrutinize the STAT3 gene for specific mutations. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and detailed insights it provides into the genetic basis of the patient’s condition. By identifying STAT3 gene mutations, healthcare providers can confirm a diagnosis of Hyper-IgE Syndrome, assess the risk of passing the condition to offspring, and tailor treatment plans to address the unique needs of each patient.

DNA Labs UAE is known for its state-of-the-art facilities and expert team of geneticists and medical professionals, ensuring high accuracy and reliability of test results. The STAT3 Gene Hyper-IgE Recurrent Infection Syndrome Genetic Test is a testament to the lab’s commitment to offering advanced genetic testing services to diagnose and manage a wide range of genetic disorders effectively.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

STAT3 Gene Hyper-IgE Recurrent Infection Syndrome Genetic Test

At DNA Labs UAE, we offer the STAT3 Gene Hyper-IgE Recurrent Infection Syndrome Genetic Test at a cost of AED 4400.0. This test is used to diagnose and identify mutations in the STAT3 gene that may be responsible for Hyper-IgE recurrent infection syndrome (HIES).

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Osteology Dermatology Immunology Disorders

Doctor and Test Department

This test is recommended by Dermatologists and is conducted in our Genetics department.

Pre Test Information

Prior to the STAT3 Gene Hyper-IgE Recurrent Infection Syndrome Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with STAT3 Gene Hyper-IgE recurrent infection syndrome NGS Genetic DNA Test gene STAT3.

Test Details

The STAT3 gene is responsible for encoding a protein called signal transducer and activator of transcription 3. This protein plays a crucial role in the immune system by regulating the expression of genes involved in immune responses.

Hyper-IgE recurrent infection syndrome (HIES) is a rare genetic disorder characterized by recurrent bacterial and fungal infections, elevated levels of immunoglobulin E (IgE) antibodies, and various other symptoms. HIES can be caused by mutations in the STAT3 gene, leading to impaired immune function.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify genetic variations or mutations that may be associated with a particular condition or disease. In the case of Hyper-IgE recurrent infection syndrome, NGS genetic testing can be used to identify mutations in the STAT3 gene that may be responsible for the disorder.

By identifying specific mutations in the STAT3 gene, NGS genetic testing can help confirm a diagnosis of Hyper-IgE recurrent infection syndrome and provide valuable information for genetic counseling, treatment planning, and management of the condition. It can also be used to screen family members for the presence of the mutation and assess their risk of developing the syndrome.

Test Name STAT3 Gene Hyper-IgE recurrent infection syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for STAT3 Gene Hyper-IgE recurrent infection syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with STAT3 Gene Hyper-IgE recurrent infection syndrome NGS Genetic DNA Test gene STAT3
Test Details

The STAT3 gene is responsible for encoding a protein called signal transducer and activator of transcription 3. This protein plays a crucial role in the immune system by regulating the expression of genes involved in immune responses.

Hyper-IgE recurrent infection syndrome (HIES) is a rare genetic disorder characterized by recurrent bacterial and fungal infections, elevated levels of immunoglobulin E (IgE) antibodies, and various other symptoms. HIES can be caused by mutations in the STAT3 gene, leading to impaired immune function.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify genetic variations or mutations that may be associated with a particular condition or disease. In the case of Hyper-IgE recurrent infection syndrome, NGS genetic testing can be used to identify mutations in the STAT3 gene that may be responsible for the disorder.

By identifying specific mutations in the STAT3 gene, NGS genetic testing can help confirm a diagnosis of Hyper-IgE recurrent infection syndrome and provide valuable information for genetic counseling, treatment planning, and management of the condition. It can also be used to screen family members for the presence of the mutation and assess their risk of developing the syndrome.